LI
Schedule 13D filing
Liontrust Investment Partners LLP disclosed a 5% stake in Maxcyte, Inc. (MXCT)
Liontrust Investment Partners LLP reported owning 5% of Maxcyte, Inc. (MXCT) (5,194,322 shares) in a Schedule 13D filed Oct 15, 2026.
A 13D means the holder may push for changes at the company.
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.